Skip to content

evaluation the effect of citrus aurantium on severity of primary dysmenorrhea in two models of skin massage and inhalation aromatherapy

evaluation the effect of citrus aurantium on severity of primary dysmenorrhea in two models of skin massage and inhalation aromatherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120414009463N62
Enrollment
140
Registered
2021-02-18
Start date
2021-02-14
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Participants in the study who met the inclusion criteria in the In massage group, massage will be done in the first two days of the menstrual cycle daily for 30 mi

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: satisfaction to participate in the study having a regular menstrual cycle with a duration of 3-7 days and interval of 21-35 days menarche before the age of 18 primary dysmenorrhea with a score of 5 or more in the visual Analogue scale During two consecutive cycles age 18-25 years single Iranian lack of mental or physical illness absence of gynecological disease (myoma, endometriosis, ovarian cyst, pelvic inflammatory disease, etc.) having a normal sense of smell

Exclusion criteria

Exclusion criteria: Unwillingness to continue attending the study very severe dysmenorrhea incidence of dysmenorrhea after the age of 20 allergy to citrus aurantium essential oil diagnosis of physical or mental illness during the study abnormal bleeding during the study

Design outcomes

Primary

MeasureTime frame
Percentage of people whose menstrual pain intensity has decreased after abdominal massage of citrus aurantium oil or inhalation of citrus aurantium essential oil. Timepoint: Before the intervention, after the intervention in the first cycle and after the intervention in the second cycle in the control and intervention groups. Method of measurement: visual analogue scale tool.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Behboodi Moghadam

Tehran University of Medical Sciences

Behboodi@tums.ac.ir+98 21 6105 4227

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026